Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F R Balkwill

Showing results (61-70 of 99) with videos related to

Pageof 10
Sort By:
International Journal of Cancer|November 15, 1989
Paradoxical effects of tumour necrosis factor in experimental ovarian cancerS T Malik, D B Griffin, W Fiers, et al.
Journal of the Mechanical Behavior of Biomedical Materials|March 15, 2016
Experimental validation of a flat punch indentation methodology calibrated against unconfined compression tests for determination of soft tissue biomechanicsR M Delaine-Smith, S Burney, F R Balkwill, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
Experience with human lymphoblastoid interferon in acute myelogenous leukaemia (AML)A Z Rohatiner, F R Balkwill, J S Malpas, et al.
The Journal of Pathology|May 1, 1977
Neoplastic macrophages grown from human leukaemic monocytesF R Balkwill, C R Franks, R T Oliver, et al.
Lancet (London, England)|December 7, 1991
Toxicity and reconstitution of recombinant interleukin-2 with albuminD W Miles, S J Longhurst, P G Harper, et al.
International Journal of Cancer|July 1, 1994
Expression and activity of MMPS and their regulators in ovarian cancerM S Naylor, G W Stamp, B D Davies, et al.
The Journal of Experimental Medicine|March 1, 1983
Immune human lymphocytes produce an acid-labile alpha-interferonF R Balkwill, D B Griffin, H A Band, et al.
British Journal of Cancer|December 1, 1992
Induction of soluble tumour necrosis factor receptors during treatment with interleukin-2D W Miles, D Aderka, H Engelmann, et al.
Cancer Research|June 30, 2001
Epithelial cancer cell migration: a role for chemokine receptors?C J Scotton, J L Wilson, D Milliken, et al.
Cancer Research|May 1, 1993
A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenograftsB Davies, P D Brown, N East, et al.
Pageof 10

Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
International Journal of Cancer|November 15, 1989
Paradoxical effects of tumour necrosis factor in experimental ovarian cancerS T Malik, D B Griffin, W Fiers, et al.
Journal of the Mechanical Behavior of Biomedical Materials|March 15, 2016
Experimental validation of a flat punch indentation methodology calibrated against unconfined compression tests for determination of soft tissue biomechanicsR M Delaine-Smith, S Burney, F R Balkwill, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
Experience with human lymphoblastoid interferon in acute myelogenous leukaemia (AML)A Z Rohatiner, F R Balkwill, J S Malpas, et al.
The Journal of Pathology|May 1, 1977
Neoplastic macrophages grown from human leukaemic monocytesF R Balkwill, C R Franks, R T Oliver, et al.
Lancet (London, England)|December 7, 1991
Toxicity and reconstitution of recombinant interleukin-2 with albuminD W Miles, S J Longhurst, P G Harper, et al.
International Journal of Cancer|July 1, 1994
Expression and activity of MMPS and their regulators in ovarian cancerM S Naylor, G W Stamp, B D Davies, et al.
The Journal of Experimental Medicine|March 1, 1983
Immune human lymphocytes produce an acid-labile alpha-interferonF R Balkwill, D B Griffin, H A Band, et al.
British Journal of Cancer|December 1, 1992
Induction of soluble tumour necrosis factor receptors during treatment with interleukin-2D W Miles, D Aderka, H Engelmann, et al.
Cancer Research|June 30, 2001
Epithelial cancer cell migration: a role for chemokine receptors?C J Scotton, J L Wilson, D Milliken, et al.
Cancer Research|May 1, 1993
A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenograftsB Davies, P D Brown, N East, et al.
Pageof 10